Atrial Fibrillation Trial, Recruiting (NCT03357926)

Atrial Fibrillation Trial, Recruiting NCT03357926 Sponsor: Medical University of Graz Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT03357926 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a pacemaker or a device called an implanted cardioverter defibrillator (ICD) that has a lead (wire) connected to the upper chamber of your heart
You have a score of 2 or more on a stroke risk assessment tool called the CHADS-VASc score (confirm with trial site)
Your heart is beating in a normal, regular rhythm, or your pacemaker is controlling your heart's upper chamber rhythm
Your pacemaker is pacing (sending electrical signals to) the upper chamber of your heart 50% of the time or less
Your device has switched modes (a sign it detected an irregular heartbeat) 50% of the time or less since your last device check-up

Who may not be able to join:

Your pacemaker or ICD is not working properly or has a fault
You were found to be in atrial fibrillation (a type of irregular heartbeat) at the time your device was checked
You were found to have atrial fibrillation during a 24-hour heart monitoring test (called a Holter ECG)
You have permanent atrial fibrillation, meaning your heart is always in this irregular rhythm

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4331638512544

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03357926

Sponsor: Medical University of Graz

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: +4331638512544

More information: https://clinicaltrials.gov/study/NCT03357926

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a pacemaker or a device called an implanted cardioverter defibrillator (ICD) that has a lead (wire) connected to the upper chamber of your heart
You have a score of 2 or more on a stroke risk assessment tool called the CHADS-VASc score (confirm with trial site)
Your heart is beating in a normal, regular rhythm, or your pacemaker is controlling your heart's upper chamber rhythm
Your pacemaker is pacing (sending electrical signals to) the upper chamber of your heart 50% of the time or less
Your device has switched modes (a sign it detected an irregular heartbeat) 50% of the time or less since your last device check-up

Who may not be able to join:

Your pacemaker or ICD is not working properly or has a fault
You were found to be in atrial fibrillation (a type of irregular heartbeat) at the time your device was checked
You were found to have atrial fibrillation during a 24-hour heart monitoring test (called a Holter ECG)
You have permanent atrial fibrillation, meaning your heart is always in this irregular rhythm

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University of Graz

Registry

ClinicalTrials.gov

Start date

1 March 2017

Est. completion

1 December 2025

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Frequency of occurrence of atrial high rate episodes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov